Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

LivaNova to Present Scientific Data at American Epilepsy Society 2022 Annual Meeting

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced its participation in the American Epilepsy Society (AES) 2022 Annual Meeting, taking place December 2-6 in Nashville, Tennessee. The Company’s therapies and technologies will be featured in seven scientific posters aimed at engaging clinical collaborators and deepening understanding for the treatment of drug-resistant epilepsy.

“LivaNova continues to advance neuromodulation and epilepsy clinical research worldwide in an effort to make an impact and improve the quality of life for epilepsy patients,” said Bryan Olin, PhD, Senior Vice President and Head of Product Development for Neuromodulation at LivaNova.

The scientific poster presentations feature the work of LivaNova employees and/or independent investigators. Conference attendees will have an opportunity to view these poster presentations and pose questions to presenters at the conference.

  • “Microburst VNS in Patients with Refractory Focal Onset Epilepsy.” Presented by Pegah Afra, M.D., on Saturday, December 3 from 12-2 p.m. Central.
  • “Microburst Vagus Nerve Stimulation: Safety and Efficacy Outcomes.” Presented by Cornelia Drees, M.D., on Saturday, December 3 from 12-2 p.m. Central.
  • “A Global Survey of Practice Habits for the Management of Vagus Nerve Stimulation Therapy.” Presented by Riëm El Tahry, M.D., Ph.D., on Sunday, December 4 from 12-2 p.m. Central.
  • “Emergency Department (ED) Visits and Hospitalizations Following Neurostimulation for Drug-Resistant Epilepsy (DRE).” Presented by Vanessa Danielson, MSc and Vice President of Global Health Economics, Market Access and Reimbursement at LivaNova, on Sunday, December 4 from 12-2 p.m. Central.
  • “Depression-Related Healthcare Utilization and Costs Following Neurostimulation for Drug-Resistant Epilepsy (DRE).” Presented by Reginald Lassagne, MSc and Senior Director of Reimbursement and Real-World Evidence at LivaNova, on Monday, December 5 from 12-2 p.m. Central.
  • “One-year Seizure-Freedom in Patients Treated with Adjunctive VNS Therapy in Japan.” Presented by Maxine Dibué, M.S., Ph.D., Director of Neuromodulation Medical Affairs at LivaNova, on Monday, December 5 from 12-2 p.m. Central.
  • “Vagus Nerve Stimulation in the Elderly and in Late-Onset Epilepsy.” Presented by PD Dr. med Friedhelm C. Schmitt on Monday, December 5th from 12-2 p.m. Central.

About LivaNova

LivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through innovative medical technologies, delivering life-changing improvements for both the Head and Heart. Headquartered in London, LivaNova employs approximately 3,000 employees and has a presence in more than 100 countries for the benefit of patients, healthcare professionals and healthcare systems worldwide. For more information, please visit www.livanova.com.

Safe Harbor Statement

This news release contains “forward-looking statements” concerning the Company’s goals, beliefs, expectations, strategies, objectives, plans and underlying assumptions and other statements that are not necessarily based on historical facts. These statements include, but are not limited to, statements regarding participation in upcoming events and the treatment of drug-resistant epilepsy. Actual events may differ materially from those indicated in our forward-looking statements as a result of various factors, including those factors set forth in Item 1A of the Company’s most recent Annual Report on Form 10-K, as supplemented by any risk factors contained in Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. LivaNova undertakes no obligation to update the information contained in this press release to reflect subsequently occurring events or circumstances.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.